41 – 50 of 61
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2015
-
Mark
Human Carotid Plaques With High Levels of Interleukin-16 Are Associated With Reduced Risk for Cardiovascular Events.
(
- Contribution to journal › Article
-
Mark
Elevated Plasma Levels of MMP-12 Are Associated With Atherosclerotic Burden and Symptomatic Cardiovascular Disease in Subjects With Type 2 Diabetes.
(
- Contribution to journal › Article
-
Mark
Low Levels of IgM Antibodies against an Advanced Glycation Endproduct-Modified Apolipoprotein B100 Peptide Predict Cardiovascular Events in Nondiabetic Subjects.
(
- Contribution to journal › Article
-
Mark
Expression of fibromodulin in carotid atherosclerotic plaques is associated with diabetes and cerebrovascular events.
(
- Contribution to journal › Article
-
Mark
Increased aldehyde-modification of collagen type IV in symptomatic plaques - A possible cause of endothelial dysfunction.
(
- Contribution to journal › Article
- 2014
-
Mark
Immunization with advanced glycation end products modified low density lipoprotein inhibits atherosclerosis progression in diabetic apoE and LDLR null mice
(
- Contribution to journal › Article
-
Mark
Induction of T helper 2 responses against human Apolipoprotein B100 does not affect atherosclerosis in ApoE-/- mice.
2014) In Cardiovascular Research(
- Contribution to journal › Article
-
Mark
Impaired Fibrous Repair: A Possible Contributor to Atherosclerotic Plaque Vulnerability in Patients With Type II Diabetes.
(
- Contribution to journal › Article
- 2013
-
Mark
Inhibition of nuclear factor of activated T-cells (NFAT) suppresses accelerated atherosclerosis in diabetic mice.
(
- Contribution to journal › Article
- 2012
-
Mark
High levels of IgM against methylglyoxal-modified apolipoprotein B100 is associated with less coronary artery calcification in patients with type 2 diabetes.
(
- Contribution to journal › Article